Introduction
Tuberous sclerosis complex (TSC) is an autosomal dominant neurocutaneous syndrome with a high incidence of sporadic cases and variable clinical expression. [1] [2] [3] It has an estimated frequency of 1/6000. [1, 4] Major manifestations of TSC include skin lesions in more than 95%, autism and seizures in 85%, kidney disease in 60%, mental retardation in 50%, and cardiac rhabdomyoma in 50%. [3] Mental retardation and autism are more in TSC patients who presents with generalized seizures including infantile spasms in the first 2 years of life. [1] [2] [3] We present a 1½-year-old female child with features suggestive of TSC.
Case Report
A 1½-year-old female child born out of a non-consanguineous marriage to a primi mother at 34 weeks of gestation, presented with abnormal jerky movements of both upper and lower limb for past 2 months. The development was normal for age, except for speech and language delay. Clinical and 
Discussion
The first complete description of TSC was given by Bourneville in 1880. [4] TSC is a disorder of cellular differentiation and proliferation that can affect the brain, skin, kidneys, heart, and other organs. Abnormal neuronal migration plays a major additional role in Tuberous sclerosis is a neurocutaneous syndrome characterized by abnormalities of both the integument and central nervous system. We present a case of tuberous sclerosis with rhabdomyoma in the heart. This was a 1½-year-old female child with infantile spasms and rhabdomyoma in heart with mother having neurocutaneous markers of tuberous sclerosis. Magnetic resonance imaging brain and electroencephalography findings were consistent with diagnosis.
Key words: Infantile spasms, neurocutaneous, rhabdomyoma TSC2 on 16p13.3 (tuberin). [1, 4, 5] [1, 2, 4, 5] This child had three of the major features: Subependymal nodules, cortical tubers, and rhabdomyoma.
Recent two-dimensional (2D) ECHO studies have reported that 50% of the patients with TSC have cardiac rhabdomyomas. Incidence of tuberous sclerosis is as high as 59-80% in patients with confirmed fetal rhabdomyomas. [6] Cardiac rhabdomyomas are hamartomas; they tend to be multiple and evidence exists that they involute with time. These lesions sometimes are evident on prenatal ultrasound testing and most of the patients with cardiac dysfunction present soon after birth with heart failure. [6] However, our child has no features suggestive of cardiac involvement except antenatal scan showing a cardiac mass. A few children later develop cardiac arrhythmias or cerebral thromboembolism from the rhabdomyomas. Some patients stabilize after medical treatment with digoxin and diuretics and eventually improve while others require surgery. [6] For neurological dysfunction. [1] Two genes responsible for TSC are TSC1 at chromosome 9q34 (hamartin) and existing rhabdomyomas surveillance studies should be done every 6-12 months until stabilization or involution occurs. [1] In TSC vigabatrin is the effective treatment option for infantile spasms. Other drugs which may be useful are topiramate and Adrenocorticotropic hormone.
Occasionally, children can discontinue their antiepileptic medication. [1, 2, 4] Oral rapamycin has been shown to cause regression of astrocytomas associated with TSC and may eventually be an alternative to operative therapy. [2, 5] In general in TSC the disease advances so slowly that years must elapse before one can be sure of progression. Of the severe cases, approximately 30% die before the 5 th year and 50-75% before attaining the adult age. The child with infantile spasm is at great risk of later intellectual deficit. [2, 7] 
Conclusion
Any child with fetal rhabdomyoma should be evaluated for TSC. Diagnosed cases should be followed-up regularly with neurodevelopment testing at school entrance, MRI brain, and renal ultrasound every 1-3 years during the childhood and adolescence should be carried out. Other tests such as EEG, ophthalmological examination, and 2D
ECHO are repeated only if clinical findings are present.
